The pharmaceutical industry is responsible for the research, development, production and commercialization of prescription drugs. The importance as a global sector is evident. Total revenues from all players in the field had reached nearly USD 1000 billion in 2014. North America is responsible for the largest portion, generating more than 40% of these revenues. The leading pharmaceutical companies come from the United States, Europe and Japan.

You will find on this page relevant reports covering insights, trends, statistics and much more on the pharmaceutical industry.

Enjoy!

Global

Evaluate Pharma World Preview 2017 Outlook 2023 – Evaluate Pharma – June 2017

Orphan drug report 2017 – Evaluate Pharma – February 2017

evaluate-pharma-world-preview-2016-outlook-2022-september-2016 – Evaluate Pharma – September 2016

EY – Biopharma M&A soars in 2015 – Is this the new normal – EY – January 2016

2016 Global life sciences outlook – Moving forward with cautious optimism – Deloitte – December 2016

Deloitte_Return_from_pharma_innovation_2015 – December 2015 – Deloitte

IMS_institute_GlobalUse_medicine_2020_nov17 – November 2015 – IMS Institute for Healthcare Informatics

A Breakthrough Year for Unmet Medical Needs – September 2015 – Evaluate Pharma

Biggest launches 2015 – August 2015 – Evaluate Pharma

Half Year Review 2015 – Pharma & Biotech – July 2015 – Evaluate Pharma

Jama Oncology The Global Burden of Cancer 2013 July2015

World Preview 2015 – Outlook 2020 – June 2015 – Evaluate Pharma

Healthcare 3.0: Unlocking the value of big data – 2015 – KPMG

A decade of innovation in Rare Diseases – 2005-2015 – Phrma

2014 Year in Review – 2015 – Evaluate Pharma

Drugs To Watch – 2015 – Thomson Reuters

Understanding the pharmaceutical value chain – November 2014 – IMS Institute for Healthcare Informatics

IHII_Global_Outlook_for_Medicines_through_2018 – November 2014 – IMS Institute for Healthcare Informatics

World Preview 2014 – Outlook 2020 – June 2014 – Evaluate Pharma

Healthcare IT: Top Five Digital Trends Fueling Disruption in Healthcare – 2014 – Accenture

Top drugs by worldwide sales – 2014 – Kurmann & Partners

R&D Cost of a New Medicine 2012 OHE – Office of Health Economics

USA

America’s Drug Problem – Nature Biotechnology 2016 (Analysis of the US drug pricing system) nature-biotech-americas-drug-problem-november-2016

Key cost drivers of pharmaceutical clinical trials in the United States – Clinical Trials – 2016

IMS Institute for Healthcare Informatics – Medicines Use and Spending in US 2015-2020 – April 2016

Express Scripts – Drug Trend Report 2015 – March 2016

EY-new-horizons-us-health-sector-report-2015-16 – September 2015

PWC-21st-century-pharmaceutical-collaboration-July2015 – 2015 – PriceWaterhouseCoopers – Health Research Institute

PWC-HealthResearchInstitute-Medical-Cost-Trend-2016 – 2015 – PriceWaterhouseCoopers – Health Research Institute

Academic Partnerships 2014 – 2015 – Nature Biotechnology – Bioentrepreneur

US Industry Profile 2014 – 2015 – Phrma

Europe

The Pharmaceutical Industry in Figures – 2014 – EFPIA

Interpharma Special Edition on French-speaking area Pharma Industry – 2015 (in French)

Asia

Japan Sales, Volume & Pricing – 2015 – Evaluate Pharma

Emerging Countries

Innovation in Life Sciences – Emerging Markets Focus – The Economist 2015

Financing Global Health 2014 – 2015 – IHME

Image Source